- UK court sets $392 million lump sum for Samsung to license ZTE's patents.
- The ruling is a key decision for global FRAND licensing rate disputes.
- Samsung and ZTE have the right to appeal the High Court's decision.
Back

A UK court ordered Samsung Electronics to pay a $392 million lump sum to ZTE Corp. for a license to use its mobile phone patents, setting a major benchmark for global technology licensing disputes.
In the ruling, Judge Richard Meade set the lump sum after the two companies failed to agree on renewing a previous 2021 deal, a decision that has major implications for Fair, Reasonable, and Non-Discriminatory (FRAND) licensing.
The $392 million figure is significantly more than the maximum $200 million Samsung had argued for, but less than half of the $731 million that ZTE had sought. The patents are essential for ensuring smartphone connectivity to mobile networks.
The ruling highlights London's growing role as a key jurisdiction for setting global FRAND terms after a 2020 Supreme Court decision. The outcome of this case, and potential appeals, could influence the terms of technology licensing deals worldwide, impacting costs for device makers and royalty income for patent holders.
The London case is a key part of a wider global legal battle between the two electronics giants. ZTE has also brought parallel lawsuits against Samsung in other major jurisdictions, including China, Germany, and Brazil, as it seeks to establish favorable licensing terms for its extensive portfolio of telecommunications patents.
For investors, the ruling introduces a significant new liability for Samsung, potentially impacting its quarterly earnings and setting a precedent for future licensing costs. Conversely, the decision provides a financial boost for ZTE and strengthens its position in ongoing negotiations with other smartphone manufacturers. While both Samsung and ZTE have the right to appeal, the High Court's detailed FRAND analysis will be influential in other courts where the companies are litigating.
This article is for informational purposes only and does not constitute investment advice.